Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 294,354 | 249,667 | 227,589 | 212,405 | 173,925 |
| Cost of Goods | 51,980 | 10,172 | 0 | N/A | N/A |
| Gross Profit | 242,374 | 239,495 | 227,589 | 212,405 | 173,925 |
| Operating Expenses | 190,068 | 172,227 | 124,035 | 103,638 | 71,039 |
| Operating Income | 53,286 | 67,440 | 103,554 | 108,767 | 102,886 |
| Interest Expense | 42,754 | 36,271 | 35,592 | 36,000 | 28,796 |
| Other Income | -654 | -182 | -773 | -1,190 | 9 |
| Pre-tax Income | 9,878 | 30,987 | 67,189 | 71,577 | 74,099 |
| Income Tax | 3,844 | 4,252 | 7,191 | 7,057 | 9,818 |
| Net Income Continuous | 6,034 | 26,735 | 59,998 | 64,520 | 64,281 |
| Minority Interests | 37 | 134 | 111 | 594 | 816 |
| Net Income | $5,997 | $26,601 | $59,887 | $63,926 | $63,465 |
| EPS Basic Total Ops | 0.31 | 1.28 | 2.89 | 2.89 | 3.26 |
| EPS Basic Continuous Ops | 0.31 | 1.29 | 2.89 | 2.91 | 3.30 |
| EPS Diluted Total Ops | 0.31 | 1.27 | 2.83 | 2.82 | 3.18 |
| EPS Diluted Continuous Ops | 0.31 | 1.27 | 2.84 | 2.85 | 3.22 |
| EPS Diluted Before Non-Recurring Items | 0.46 | 2.40 | N/A | N/A | N/A |
| EBITDA(a) | $162,940 | $184,618 | $185,940 | $180,958 | $155,280 |